Edition:
United States

Mauna Kea Technologies SAS (MKEA.PA)

MKEA.PA on Paris Stock Exchange

2.73EUR
26 Sep 2017
Change (% chg)

€-0.10 (-3.53%)
Prev Close
€2.83
Open
€2.81
Day's High
€2.82
Day's Low
€2.72
Volume
73,549
Avg. Vol
278,935
52-wk High
€3.94
52-wk Low
€1.85

Chart for

About

Mauna Kea Technologies SAS, also known as Mauna Kea Technologies SA, is a France-based company active in the healthcare business sector. It specializes in designing, developing, and selling medical imaging tools and systems. The Company’s products, used mainly in endoscopy, are intended for viewing and detecting deficiencies in... (more)

Overall

Beta: 0.75
Market Cap(Mil.): €49.42
Shares Outstanding(Mil.): 19.16
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 192.64 15.95
EPS (TTM): -- -- --
ROI: -- 9.62 15.19
ROE: -- 14.95 13.87

BRIEF-Mauna Kea Technologies announces worldwide commercialization of Cellvizio

* ANNOUNCED ON TUESDAY THAT UROLOGY DIVISION OF COOK MEDICAL HAS OFFICIALLY LAUNCHED WORLDWIDE COMMERCIALIZATION OF CELLVIZIO AS PART OF THE STRATEGIC PARTNERSHIP ANNOUNCED BY THE TWO COS AT END OF 2015

Sep 06 2017

BRIEF-Mauna Kea Technologies: multicenter randomized controlled trial shows improved early stomach cancer detection with Cellvizio

* SAYS MULTICENTER RANDOMIZED CONTROLLED TRIAL SHOWS IMPROVED EARLY STOMACH CANCER DETECTION WITH CELLVIZIO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Aug 02 2017

BRIEF-Mauna Kea Technologies announces benefits of using Cellvizio for characterizing upper urinary tract cancer

* MAUNA KEA TECHNOLOGIES: NEW PUBLICATION CONFIRMS BENEFITS OF USING CELLVIZIO FOR CHARACTERIZING UPPER URINARY TRACT CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 19 2017

BRIEF-Mauna Kea Technologies announces new peer-reviewed publication on Cellvizio

* Mauna Kea Technologies announces new peer-reviewed publication reports further external validation of unmatched Cellvizio endomicroscopy performance and inter-observer agreement in the characterization of pancreatic cysts

Mar 27 2017

Earnings vs. Estimates